
Opinion|Videos|November 5, 2025
Selecting Anti-VEGF Therapies in Retinal Vascular Disease Management
Author(s)Peter K Kaiser, MD
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves NDA labeling supplement allowing re-administration of iDose TR
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
Dr. Mali’s top 5 predictions in ophthalmology for 2026
4
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
5




























